NCT07064473: EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- State
- Under way
- Phase
- Phase 3
- People
- 11,800 planned
- Started
- 22 Jul 2025
- Primary completion
- 14 Dec 2029
- Arms
- Vicadrostat + empagliflozin treatment arm
- Results
- None posted
- 14 Jul 2025: Trial registered
- 22 Jul 2025: Trial started